Medicine and Dentistry
Cardiovascular System
100%
Heart Failure
92%
Percutaneous Coronary Intervention
66%
Cardiovascular Disease
62%
Chronic Total Occlusion
59%
Myocardial Infarction
40%
Maturity Onset Diabetes of the Young
34%
Diabetes
32%
Blood Pressure
30%
Disease
27%
Meta-Analysis
25%
Cardiovascular Risk
25%
Hazard Ratio
24%
Atherosclerosis
24%
Revascularization
23%
Prevalence
23%
Apoplexy
23%
Biological Marker
23%
Exercise
23%
Coronary Artery
22%
Acute Coronary Syndrome
22%
Coronary Artery Disease
22%
Heart Failure with Preserved Ejection Fraction
21%
Atrial Fibrillation
20%
Acute Heart Infarction
20%
Diabetes Mellitus
20%
Hemodynamic
20%
Odds Ratio
19%
Ejection Fraction
18%
Drug Therapy
17%
Isotopes of Calcium
17%
Placebo
17%
COVID-19
17%
Body Mass Index
16%
Patient with Type 2 Diabetes
16%
Implantable Automatic Defibrillator
16%
Brain Natriuretic Peptide
15%
Athletes
15%
Drug-Eluting Stent
15%
Left Ventricular Hypertrophy
14%
Health Care Cost
14%
Saphenous Vein Graft
14%
Clinical Trial
13%
Congestive Heart Failure
13%
Symptom
13%
Cardiorespiratory
13%
Randomized Controlled Trial
13%
Ischemic Heart Disease
12%
Chronic Kidney Disease
12%
Stroke Volume
12%
ST Segment Elevation Myocardial Infarction
12%
Arteriosclerosis Obliterans
12%
Cardiac Troponin
12%
Systolic Blood Pressure
12%
Heart Output
11%
Patient with Diabetes
11%
Medicare
11%
Heart Disease
11%
Statin
11%
Artery
11%
Hypertrophic Cardiomyopathy
11%
Sudden Cardiac Death
10%
Cardiology
10%
Acute Decompensated Heart Failure
10%
Systematic Review
10%
Echocardiography
10%
Heart Arrest
10%
Defibrillator
10%
Heart Transplantation
9%
Amino Terminal Sequence
9%
Combination Therapy
9%
Magnetic Resonance Imaging
9%
Cardiac Dysrhythmia
9%
Cardiac Magnetic Resonance Imaging
9%
Heart Left Ventricle Ejection Fraction
9%
Resuscitation
9%
Risk Stratification
9%
Diagnosis
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Sudden Death
9%
All Cause Mortality
9%
Heart Graft
9%
Obesity
9%
Heart Failure with Reduced Ejection Fraction
8%
Heart Muscle Revascularization
8%
Commotio Cordis
8%
Physical Activity
8%
Hospital Mortality
8%
Ventricular Fibrillation
8%
Adverse Event
8%
Low Density Lipoprotein Cholesterol
8%
Mean Arterial Pressure
8%
Left Ventricular Assist Device
8%
Stenting
8%
Natriuretic Factor
8%
Heart Ventricle Remodeling
8%
Injury
8%
Oxygen Consumption
8%
Cardiomyopathy
8%
Cohort Analysis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
84%
Cardiovascular Disease
50%
Heart Infarction
46%
Non Insulin Dependent Diabetes Mellitus
40%
Disease
31%
Placebo
30%
Cardiovascular Risk
27%
Coronary Artery Atherosclerosis
22%
Acute Coronary Syndrome
22%
Coronary Artery Disease
21%
Acute Heart Infarction
21%
Diabetes Mellitus
19%
Chronic Total Occlusion
19%
Biological Marker
18%
Prevalence
18%
Atherosclerosis
17%
Antihypertensive Agent
16%
Brain Natriuretic Peptide
16%
Atrial Fibrillation
15%
Statin (Protein)
14%
All Cause Mortality
13%
Randomized Controlled Trial
13%
Congestive Heart Failure
13%
Clinical Trial
13%
Heart Disease
12%
Chronic Kidney Failure
12%
Heart Arrhythmia
12%
ST Segment Elevation Myocardial Infarction
11%
Ischemic Heart Disease
11%
Acute Heart Failure
11%
Diuretic Agent
10%
Bleeding
10%
Randomized Clinical Trial
10%
Combination Therapy
10%
Heart Failure with Preserved Ejection Fraction
10%
Mouse
10%
Dapagliflozin
10%
Adverse Event
9%
Cardiomyopathy
9%
Troponin T
9%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Troponin
8%
Low Density Lipoprotein Cholesterol
8%
Symptom
8%
Pharmacotherapy
8%
Natriuretic Factor
8%
Acetylsalicylic Acid
8%
C Reactive Protein
8%
Cohort Study
8%
Hospital Mortality
8%
Heart Ventricle Arrhythmia
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
High Density Lipoprotein Cholesterol
7%
Obesity
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Malignant Neoplasm
6%
Hypertensive Factor
6%
Heart Left Ventricle Hypertrophy
6%
Ischemia
6%
Injury
6%
Hemoglobin A1c
6%
Heart Failure with Reduced Ejection Fraction
6%
Heart Muscle Ischemia
6%
Peripheral Occlusive Artery Disease
5%
Heart Ventricle Remodeling
5%
Hypertension
5%
Heart Ventricle Tachycardia
5%
Heart Arrest
5%
Non ST Segment Elevation Myocardial Infarction
5%
Mortality Rate
5%
Unstable Angina Pectoris
5%
Troponin I
5%
Inflammation
5%
Beta Adrenergic Receptor Blocking Agent
5%
Hypertrophic Cardiomyopathy
5%
Fibrinolytic Agent
5%
Comorbidity
5%
Antihypertensive Therapy
5%
Heart Left Ventricle Failure
5%
Keyphrases
Heart Failure
39%
Percutaneous Coronary Intervention
28%
Type 2 Diabetes Mellitus (T2DM)
27%
Chronic Total Occlusion
25%
Confidence Interval
25%
Hypertension
21%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
Myocardial Infarction
19%
Cardiovascular Disease
19%
Cardiovascular Outcomes
17%
Cardiovascular Risk
17%
Hazard Ratio
16%
Atherosclerotic Cardiovascular Disease (ASCVD)
16%
Blood Pressure
15%
Type 2 Diabetic Patients
15%
Placebo
15%
Diabetes
14%
High Risk
14%
Cardiovascular Mortality
14%
Dallas Heart Study
12%
Patients with Heart Failure
12%
Acute Coronary Syndrome
11%
Hypertension Management
11%
Meta-analysis
11%
United States
11%
Heart Failure Hospitalization
11%
Clinical Outcomes
11%
COVID-19
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Cardiovascular Events
10%
Chronic Kidney Disease
10%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
10%
Coronary Artery Disease
10%
ST-elevation Myocardial Infarction (STEMI)
10%
Acute Myocardial Infarction
9%
Risk Factors
9%
Heart Rate
9%
All-cause Mortality
9%
Atrial Fibrillation
9%
Odds Ratio
9%
Major Adverse Cardiovascular Events
9%
Patients with Diabetes
9%
Randomized Controlled Trial
8%
Left Ventricular Function
8%
Revascularization
8%
Acute Decompensated Heart Failure
8%
Hospitalization
8%
Mean Arterial Pressure
7%
Older Adults
7%
Statins
7%
Cardiomyocytes
7%
Obesity
7%
Ventricular Arrhythmia
7%
Randomized Clinical Trial
7%
Muscle Sympathetic Nerve Activity
6%
Body Mass Index
6%
Dapagliflozin
6%
Cardiac Function
6%
Coronary Artery Calcium
6%
Clinical Practice Guidelines
6%
Cardiac Output
6%
Peripheral Arterial Disease
6%
Drug-eluting Stent
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
6%
Exercise Pressor Reflex
6%
Scientific Statement
6%
Low-density Lipoprotein Cholesterol (LDL-C)
6%
Heart Disease
6%
Secondary Prevention
6%
Sudden Cardiac Death
6%
Cardiovascular Reactivity
5%
Implantable Defibrillator
5%
Coronary Chronic Total Occlusion
5%
Cardiorespiratory Fitness
5%
Diuretics
5%
Saphenous Vein Graft
5%
High-density Lipoprotein Cholesterol (HDL-C)
5%
Clinical Trials
5%
Left Ventricular Hypertrophy
5%
Randomized Trial
5%
Coronary Artery Bypass Graft Surgery
5%
Autophagy
5%
Left Ventricular Ejection Fraction
5%
Lower Body Negative Pressure
5%
Arrhythmia
5%
Beta-blockers
5%
Estimated Glomerular Filtration Rate
5%
Exercise Training
5%